Skip to main content

Table 3 Contraceptive prevalence (N = 238)

From: Reproductive care in Thai women with diabetes mellitus: a descriptive cross-sectional study

Variables

Total (N = 238) n (%)

Did not use contraceptives

86 (36.1)

 Not sexually active in the past 12 months

70 (81.4)

 Sexually active in the past 12 months

16 (18.6)

Use of contraceptive

152 (63.9)

 Combined oral contraceptive pills

37 (24.3)

 Contraceptive patch

0 (0)

 Progesterone-only pills

1 (0.7)

 DMPAa

9 (5.9)

 Contraceptive implant(s)

7 (4.6)

 Female Sterilization

31 (20.4)

 Male Sterilization

2 (1.3)

 Copper IUDb

1 (0.7)

 LNG-IUSc

0 (0)

 Male condoms

44 (29)

 Female condoms

2 (1.3)

 Diaphragm

0 (0)

 Withdrawal method

14 (9.2)

 Lactation amenorrhea

1 (0.7)

Contraceptive prevalence

 Contraceptive prevalence among sexually active women

90.5 (152/168)

 Modern contraceptive prevalence among sexually active womend

81.6 (137/168)

 Tier 1 and 2 contraceptive prevalence among sexually active womene

54.2 (91/168)

  1. aDepot medroxyprogesterone acetate
  2. bCopper intrauterine device
  3. cLevonogestrel intrauterine system
  4. dModern contraceptives including any medical intervention used for contraception [24]
  5. eTier 1 and 2 contraceptive prevalence include sterilization, hormonal contraception, and lactation amenorrhea [25]